Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abiraterone, aimed, Bedford, castration, College, complement, cREPO, dosed, Eclipse, endpoint, enzalutamide, exit, feedback, fewer, half, heterogeneity, hormone, immunohistochemistry, intra, King, London, lung, MI, population, progressed, progression, quantifying, radiographic, randomized, renovated, renovation, resistant, secondary, solution, SPECT, technique, tumor, UK, voucher
Removed:
alleged, appeal, appealed, baseline, biochemical, breached, burden, claimed, Cohort, complaint, CONDOR, Confirmation, continuum, conventional, correct, demonstrated, deposit, Deutschland, discharge, discovery, dismissing, District, division, ehf, embodied, EPO, experienced, failed, fastest, fractional, Germany, GmbH, hearing, Heidelberg, highest, improvement, Insight, intervene, July, Kabi, lieu, long, low, Mannheim, margin, median, methylnaltrexone, MIP, motion, multiple, neuroblastoma, October, opposition, optimize, oral, OSPREY, ownership, patentability, periodic, petition, pivotal, predictive, proof, prosecution, PTAB, PTC, regional, relied, remitted, replacement, resurgence, review, revocation, revoked, security, SNMMI, specificity, sponsored, stating, studied, support, termination, Trademark, USPTO, wholly, withdrew, work, written
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view